Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
Clinical trial NCT04741997 · RECRUITING
Trial details
- NCT number
- NCT04741997
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-24
- Primary completion
- 2026-07-22
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.